You are here: Industry Insights > Market News > Unichem gets US FDA approval for Tolterodine Tartrate tablets

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Unichem gets US FDA approval for Tolterodine Tartrate tablets

expresspharmaAugust 07, 2020

Tag: Unichem , FDA , Tolterodine Tartrate tablets

Favorites

Unichem Laboratories has received ANDA approval for its Tolterodine Tartrate Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of DETROL (tolterodine tartrate) tablets of Pfizer.

Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

The product will be commercialised from Unichem’s Goa plant.

Previous:AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine

Next:Guangxi GengYuan Flavors and Fragrances Co., Ltd. - Exhibitor Webinar

Study Results of Orelabrutinib in Patients with ITP Published by the American Journal of Hematology

PharmaSourcesApril 18, 2024

The study provides compelling evidence for the potential of orelabrutinib as a safe and effective therapy for patients with ITP.

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

PharmaSourcesApril 17, 2024

Toxys Reports Positive Results from the OECD Ring Trial Validation of ToxTracker in a Peer-Reviewed Article

Biotech NewswireApril 10, 2024

Unichem gets US FDA approval for Tolterodine Tartrate tablets | Pharmasources.com

Celonic Launches New GS-CHOvolution® Cell Line Expression System

Biotech NewswireApril 10, 2024

GS-CHOvolution® is based on Revvity’s CHOSOURCE™ expression platform and TnT transposon technology.

Unichem gets US FDA approval for Tolterodine Tartrate tablets

Related News

Study Results of Orelabrutinib in Patients with ITP Published by the American Journal of Hematology

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Toxys Reports Positive Results from the OECD Ring Trial Validation of ToxTracker in a Peer-Reviewed Article

Celonic Launches New GS-CHOvolution® Cell Line Expression System

You may like